Loading clinical trials...
Loading clinical trials...
EuRhythDia II is a multicenter, randomized, double-blind controlled study. The rationale of EuRhythdia is to explore the effects of 12 weeks of timed melatonin treatment on circadian rhythm, metabolic...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
NCT06473415 · Critical Illness, Delirium, and more
NCT05683483 · Sleep, Sleep Disturbance, and more
NCT06970418 · Attention Deficit Disorder With Hyperactivity, Sleep Disorders, Circadian Rhythm, and more
NCT06953765 · Lung Cancer (NSCLC), Sleep Disorders, Circadian Rhythm, and more
NCT06821672 · Preterm, Chronobiology, and more
University Medical Center Aachen
Aachen, North Rhine-Westphalia
CTC North GmbH & Co. KG
Hamburg
Department of Systems Medicine
Rome, Lazio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions